Literature DB >> 21997625

Evergreening: a common practice to protect new drugs.

Kate S Gaudry1.   

Abstract

Mesh：

Year:  2011        PMID： 21997625     DOI： 10.1038/nbt.1993

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  The link between gross profitability and pharmaceutical R&D spending.

Authors:  F M Scherer
Journal:  Health Aff (Millwood)       Date:  2001 Sep-Oct       Impact factor: 6.301
  1 in total
  6 in total

1.  Limiting "evergreening" for a better balance of drug innovation incentives.

Authors:  Matthew B Stanbrook
Journal:  CMAJ       Date:  2013-07-22       Impact factor: 8.262

Review 2.  Insights into Computational Drug Repurposing for Neurodegenerative Disease.

Authors:  Manish D Paranjpe; Alice Taubes; Marina Sirota
Journal:  Trends Pharmacol Sci       Date:  2019-07-17       Impact factor: 14.819

Review 3.  Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2015-10       Impact factor: 6.447

4.  Patent office backlog adds billions to national drug expenditure.

Authors:  Kate S Gaudry; Daniel E Cummings
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

5.  Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants.

Authors:  Ali A Alkhafaji; Ludovic Trinquart; Gabriel Baron; Moïse Desvarieux; Philippe Ravaud
Journal:  BMC Med       Date:  2012-11-20       Impact factor: 8.775

6.  Overcoming obstacles to repurposing for neurodegenerative disease.

Authors:  Diana W Shineman; John Alam; Margaret Anderson; Sandra E Black; Aaron J Carman; Jeffrey L Cummings; Penny A Dacks; Joel T Dudley; Donald E Frail; Allan Green; Rachel F Lane; Debra Lappin; Tanya Simuni; Richard G Stefanacci; Todd Sherer; Howard M Fillit
Journal:  Ann Clin Transl Neurol       Date:  2014-06-24       Impact factor: 4.511
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.